Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pharmaceutical Patent Analyst|November 7, 2014
New spleen tyrosine kinase inhibitors: patent applications published during 2011-2013Atli Thorarensen, Neelu Kaila
Current Medicinal Chemistry|July 29, 2004
Advances in the discovery of novel antibacterial agents during the year 2002Christina R Harris, Atli Thorarensen
Expert Opinion on Therapeutic Patents|November 16, 2010
An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and PortolaWilliam J Moore, David Richard, Atli Thorarensen
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Understanding CXCR2 antagonism with a dynamic allosteric ternary complex modelRui Li, Richard Frisbie, Fabien Vincent, et al.
Journal of Chemical Information and Modeling|December 10, 2015
Target the More Druggable Protein States in a Highly Dynamic Protein--Protein Interaction SystemZuojun Guo, Atli Thorarensen, Jianwei Che, et al.
The Journal of Organic Chemistry|October 24, 2001
A Versatile Route to 2-Substituted Cyclic 1,3-Dienes via a Copper(I)-Catalyzed Cross-Coupling Reaction of Dienyl Triflates with Grignard ReagentsA. Sofia E. Karlström, Magnus Rönn, Atli Thorarensen, et al.
Recent Patents on Inflammation & Allergy Drug Discovery|February 2, 2012
The 2010 patent landscape for spleen tyrosine kinase inhibitorsAlessandro F Moretto, Christoph Dehnhardt, Neelu Kaila, et al.
Organic Letters|July 30, 2009
Synthesis of tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylateMarvin J Meyers, Inouk Muizebelt, Jim van Wiltenburg, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitorAtli Thorarensen, Ronald W Sarver, Fang Tian, et al.
Pageof 4